These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Changes of peroxisome proliferator-activated receptor-γ on crushed rat sciatic nerves and differentiated primary Schwann cells. Cao Y; Wang Q; Zhou Z; Wang Y; Liu Y; Ji Y; Liu F J Mol Neurosci; 2012 Jun; 47(2):380-8. PubMed ID: 22094441 [TBL] [Abstract][Full Text] [Related]
10. WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway. Fakhfouri G; Ahmadiani A; Rahimian R; Grolla AA; Moradi F; Haeri A Neuropharmacology; 2012 Sep; 63(4):653-66. PubMed ID: 22634229 [TBL] [Abstract][Full Text] [Related]
11. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats. Kobayashi N; Ohno T; Yoshida K; Fukushima H; Mamada Y; Nomura M; Hirata H; Machida Y; Shinoda M; Suzuki N; Matsuoka H Am J Hypertens; 2008 May; 21(5):576-81. PubMed ID: 18437150 [TBL] [Abstract][Full Text] [Related]
13. PPAR-gamma agonists as regulators of microglial activation and brain inflammation. Bernardo A; Minghetti L Curr Pharm Des; 2006; 12(1):93-109. PubMed ID: 16454728 [TBL] [Abstract][Full Text] [Related]
14. Rho/ROCK pathway and neural regeneration: a potential therapeutic target for central nervous system and optic nerve damage. Tan HB; Zhong YS; Cheng Y; Shen X Int J Ophthalmol; 2011; 4(6):652-7. PubMed ID: 22553739 [TBL] [Abstract][Full Text] [Related]
15. Emodin, A Chinese Herbal Medicine, Inhibits Reoxygenation-Induced Injury in Cultured Human Aortic Endothelial Cells by Regulating the Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) and Endothelial Nitric Oxide Synthase (eNOS) Signaling Pathway. Shou X; Zhou R; Zhu L; Ren A; Wang L; Wang Y; Zhou J; Liu X; Wang B Med Sci Monit; 2018 Feb; 24():643-651. PubMed ID: 29386501 [TBL] [Abstract][Full Text] [Related]
16. Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway. Lu Y; Sun Y; Zhu J; Yu L; Jiang X; Zhang J; Dong X; Ma B; Zhang Q Cell Death Dis; 2018 Jan; 9(1):15. PubMed ID: 29323103 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic augmentation of the growth hormone axis to improve outcomes following peripheral nerve injury. Tuffaha SH; Singh P; Budihardjo JD; Means KR; Higgins JP; Shores JT; Salvatori R; Höke A; Lee WP; Brandacher G Expert Opin Ther Targets; 2016 Oct; 20(10):1259-65. PubMed ID: 27192539 [TBL] [Abstract][Full Text] [Related]
18. The Journey of Thiazolidinediones as Modulators of PPARs for the Management of Diabetes: A Current Perspective. Ahsan W Curr Pharm Des; 2019; 25(23):2540-2554. PubMed ID: 31333088 [TBL] [Abstract][Full Text] [Related]
19. PPARgamma agonists upregulate the barrier function of tight junctions via a PKC pathway in human nasal epithelial cells. Ogasawara N; Kojima T; Go M; Ohkuni T; Koizumi J; Kamekura R; Masaki T; Murata M; Tanaka S; Fuchimoto J; Himi T; Sawada N Pharmacol Res; 2010 Jun; 61(6):489-98. PubMed ID: 20227502 [TBL] [Abstract][Full Text] [Related]